CMS has released their latest round of drug pricing data, giving us further insights into how the prescription drug supply chain is responding to the new challenges and demands presented by the COVID-19 pandemic. While many expected the pressures to cause massive shortages and price increases, the data shows that while shortages have definitely jumped, this new CMS drug pricing data shows that not only have generic drug prices stayed in check, but they actually appear to be deflating! But of course, the details matter, and we’ve got them for you.
Read More
It’s NADAC survey results week, which means it’s time for our next installment of “what happened to generic drug prices last month.” We saw more price increases this past month, but an overall decrease in annualized spending based on typical utilization trends. As always, the details matter, and we’re here to provide them for you. Check out our latest drug pricing report for a lot of important updates on the latest generic drug price changes, plus an updated NADAC Packed Bubble Chart. Happy New Year.
Read More
It’s NADAC survey results week, which means it’s time for our next installment of “what happened to generic drug prices last month.” We saw a lot of price decreases this past month, and an overall decrease in annualized spending. As always, the details matter, and we’re here to provide them for you. Check out our latest drug pricing report for a lot of important updates, plus an updated NADAC Packed Bubble Chart. And new this month, a look at generic pricing volatility!
Read More
It’s NADAC survey results week, which means it’s time for our next installment of “what happened to generic drug prices last month.” On a positive note, it looks like there was a substantial amount of generic deflation in the aggregate. As always, the details matter, and we’re here to provide them for you. Check out our latest drug pricing report for a lot of important updates, plus an updated and upgraded NADAC Packed Bubble Chart!
Read More
It’s NADAC survey results week, which means it’s time for our fifth installment of “what happened to generic drug prices last month.” On a positive note, it looks like there was a bit of net deflation. But overall it was a less than stellar month for generic deflation - it was the first month (since we started this monthly review) where we saw more generic drug price increases then decreases. As always, the details matter, and we’re here to provide them for you. Check out our latest drug pricing report for a lot of important updates, plus an updated NADAC Packed Bubble Chart!
Read More